Management of Sleep Fragmentation Without Obstructive Sleep Apnea
This patient has sleep fragmentation (unstable sleep 43%, stable sleep only 16%) without obstructive sleep apnea, and should be evaluated and treated for chronic insomnia disorder using cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment.
Clinical Interpretation
Your polysomnography findings reveal significant sleep instability despite:
- No obstructive events
- Adequate total sleep duration
- REM sleep achievement
- Stable vital signs
The markedly low stable sleep percentage (16%) and high unstable sleep (43%) indicate sleep fragmentation consistent with insomnia disorder, not a breathing-related sleep disorder. Recent research demonstrates that REM instability and sleep fragmentation are detectable objective markers of chronic insomnia even when conventional polysomnography macrostructure appears normal 1.
Primary Recommendation: Cognitive Behavioral Therapy for Insomnia
Initiate CBT-I as first-line treatment 2. This is a strong recommendation based on moderate-quality evidence showing:
- Improved global outcomes (increased remission, treatment response)
- Reduced sleep onset latency and wake after sleep onset
- Improved sleep efficiency and quality
- Minimal harms (likely mild if any)
CBT-I Components Include:
- Cognitive therapy addressing sleep-related thoughts and worries
- Behavioral interventions: sleep restriction and stimulus control
- Sleep hygiene education
Delivery Options:
- Individual or group therapy sessions
- Telephone-based or web-based modules
- Self-help resources
- Can be performed in primary care settings 2
Secondary Consideration: Pharmacologic Therapy
If CBT-I alone is unsuccessful, use shared decision-making to discuss adding short-term pharmacologic therapy 2. This is a weak recommendation based on low-quality evidence.
Important Caveats About Medications:
- FDA warns about cognitive and behavioral changes, driving impairment, and motor vehicle accidents
- Observational data suggest associations with dementia and fractures 2
- Recommended for short-term use only
- Lower doses recommended for women and older adults
- Options include eszopiclone, zolpidem, or suvorexant for short-term improvement 3
Clinical Pitfalls to Avoid
- Do not pursue further sleep apnea testing - polysomnography is not indicated for routine reassessment in this scenario 4
- Do not assume normal total sleep time means no sleep disorder - sleep fragmentation is the key pathology here
- Do not start with medications - CBT-I must be first-line 2
- Do not ignore this finding - sleep fragmentation reflects clinically significant insomnia requiring treatment
Follow-Up Considerations
Reassess if:
- Clinically significant weight changes occur
- New cardiovascular symptoms develop
- Symptoms persist despite good treatment adherence 4
The sleep fragmentation pattern you describe represents objective evidence of insomnia disorder pathophysiology, warranting active treatment rather than reassurance alone.